In conclusion, NFATc3 and VIP inextricably linked via a regulatory relationship in both COPD and IPF, supporting the concept that pathogenesis is mediated by NFATc3 and VIP may have a novel therapeutic role. The gene discussed is NFATC3; the disease is chronic obstructive pulmonary disease.